FDA approves Moderna's mRNA flu vaccine after initially refusing to review it

The mFlusiva vaccine will soon be available for adults aged 50 and over.
Live Science on MSN

FDA approves first mRNA vaccine for seasonal flu

The Food and Drug Administration's approval of an mRNA vaccine for flu comes after the agency initially refused to review the ...

F.D.A. Approves Moderna’s mRNA Flu Vaccine

The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
Just The NewsOpinion

Return of the rubber stamp? First mRNA flu vaccine has far higher injury rate than standard jabs

Moderna's own research shows 5,000 novel jabs required to prevent one hospitalization over standard vaccine. "Pharma finished ...
Everyday Health on MSN

FDA Approves First mRNA Flu Vaccine for Adults 50 and Older

Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...
New Atlas

First mRNA flu vaccine has been approved for US adults

In a somewhat surprise announcement, the Food and Drug Administration (FDA) has approved the first US influenza vaccine built ...

FDA approves first mRNA-based flu vaccine

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...

FDA approves Moderna's mRNA seasonal flu vaccine

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday. The vaccine, mFLUSIVA, is ...